Table 1.
Pathway | Physiologic Conditions | Environmental Triggers | *Biologic Factors | *Small Molecules/Transcription Factors |
---|---|---|---|---|
β-Cell Expansion | Pregnancy12-14 Obesity15-20 Insulin Resistance21-22 Development28-30 |
β-Cell Ablation23-27 Partial Pancreatectomy41 |
Glucose47-48 GLP-1 Betatrophin54 Serotonin62 Lactogens14,58-62 Osteocalcin58-59 |
**cMyc, ChREBP, NKX6.1, Cdk6, FoxM135-39 Glucokinase activators, Sulfonylureas50 L-type calcium channel agonists, phorbol esters, Wnt agonists51 WS664 Adenosine agonists66 Adenosine Kinase Inhibitors (ADKI's)65-66 |
β-Cell Neogenesis | Development | Pancreatic Duct Ligation/Partial Pancreatectomy27,79-83,88-91 | - | Pax487,91 |
β-Cell Trans-differentiation | - | β-Cell Ablation23,116 | - | Pdx1101 NeuroD +/− Betacellulin102 Pdx1+NeuroD/Ngn3103 Pdx1+MafA+Ngn3/NeuroD105 **Combinatorial Culture Conditions107 BRD7389110 FoxO1118 |
Biologic factors and small molecules listed are limited to those discussed in the review
In-vitro